FRESENIUS MEDICAL CARE VENTURES - Key Persons
Job Titles:
- Director Investor Relations
Job Titles:
- Chairman of the Nomination Committee
- Chairman of the Supervisory Board
- Vice Chairman of the Human Resources Committee
- Vice Chairman of the Nomination Committee
- Vice Chairman of the Supervisory Board
- Chairman of the
Job Titles:
- Head of Investor Relations, Strategic Development & Communications, EVP
Job Titles:
- Lead Independent Director
- Member of the Nomination Committee
- Member of the Supervisory Board
- Vice Chair of the Audit and Corporate Governance Committee
- Vice Chairman of the Joint Committee
- Member of the
In her role as Lead Independent Director, Dr. Dorothea Wenzel is responsible for addressing environmental, social and governance (ESG) aspects on the Supervisory Board as well as to develop and propose measures on such aspects.
Dr. Dorothea Wenzel has been appointed as Lead Independent Director on May 20, 2021 and has in-depth ESG expertise. This includes the areas of reporting and regulation, ESG strategies and initiatives, and the formulation of ESG targets. Dr. Wenzel regularly participates in external trainings to further deepen her existing knowledge and stay informed about current developments. In close exchange with the Global Sustainability team, she has familiarized herself with the structures, processes and focus areas of Fresenius Medical Care's sustainability management.
Dr. Katarzyna Mazur-Hofsäß took over responsibility for the globally operating Care Enablement segment, in which Fresenius Medical Care is consolidating its healthcare products business under a global MedTech umbrella, effective January 1, 2022. Previously, she served as Chief Executive Officer for EMEA since September 1, 2018. Since 2013 she was president for EMEA at the med-tech company Zimmer Biomet. In her 25 years of professional career Katarzyna has gained extensive international experience in executive general management positions. She is a physician by educational background and holds a Ph.D. from Gdansk Medical University in Poland, as well as an MBA from the Warsaw School of Economics and the University of Minnesota.
Franklin W. Maddux, MD was appointed Global Chief Medical Officer in 2019 and appointed to the Management Board on January 1, 2020. He is an expert nephrologist, IT entrepreneur and healthcare executive with more than 30 years of experience in healthcare. He joined the company in 2009 as Executive Vice President for Clinical & Scientific Affairs and Chief Medical Officer for Fresenius Medical Care North America, where he was responsible for the delivery of high-quality, value-based care for the largest integrated renal care network on the continent. His expertise and research interests have focused on quality care for chronic kidney disease patients around the world.
Job Titles:
- Member of the Supervisory Board
- Member of the
Job Titles:
- Acting Chief Financial Officer
- Chief Executive Officer
- CEO and Acting CFO
Helen Giza was appointed Chief Executive Officer effective December 6, 2022. She will continue to serve as Chief Financial Officer until a successor is appointed for this position. Helen Giza joined Fresenius Medical Care in 2019 as Chief Financial Officer and took on the additional role of Chief Transformation Officer heading the FME25 transformation program in 2021. Previously, she has been Chief Integration and Divestiture Management Officer at Takeda Pharmaceuticals since 2018. Before joining the Takeda Corporate Executive Team, she served as Chief Financial Officer of Takeda's U.S. business unit since 2008. Prior to that she held a number of key international finance and controlling positions, amongst others at TAP Pharmaceuticals and Abbott Laboratories. Helen Giza is a U.K. Chartered Certified Accountant and holds a Master of Business Administration from the Kellogg School of Management at Northwestern University in Evanston, Illinois, USA.
Job Titles:
- Vice President Investor Relations
Job Titles:
- Spokesperson Media Relations
Job Titles:
- Chairman of the Human Resources Committee
- Chairman of the Joint Committee
- Chairman of the Nomination Committee
- Chairman of the Supervisory Board
Job Titles:
- Executive Assistant & Office Manager to EVP, Head of Investor Relations & Strategic Development & Communications
Job Titles:
- Chairman of the Audit and Corporate Governance Committee
- Member of the Supervisory Board
- Member of the
Job Titles:
- Vice President Investor Relations & Deputy Head Investor Relations, Strategic Development & Communications
Job Titles:
- Member of the Audit and Corporate Governance Committee
- Member of the Human Resources Committee
- Member of the Joint Committee
- Member of the Supervisory Board
- Vice Chairman of the Nomination Committee
- Vice Chairman of the
Job Titles:
- Member of the Joint Committee
- Member of the Supervisory Board
William Valle leads the globally operating Care Delivery segment, in which the company is combining its global healthcare services business effective January 1, 2022. Previously, he served as Chief Executive Officer for North America since February 17, 2017. Prior to that, he was Executive Vice President responsible for the dialysis service business and vascular access business of Fresenius Medical Care North America from 2014 to 2017. Bill joined Fresenius Medical Care in 2009 and has more than 30 years of experience in the dialysis industry, holding executive positions in sales, marketing and business development at several dialysis companies including Gambro Healthcare, Inc.